Hims & Hers Health, Inc., the leading health and wellness platform, today announced an acquisition that will further verticalize the company's long-term ability to deliver personalized medications.

Geron Corporation , a commercial-stage biopharmaceutical company, today announced that members of the management team are scheduled to participate in fireside chats at the following investor ...

Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized ...

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. RedCloud - London ...

today announced the closing of its initial public offering of 26,450,000 shares of its common stock at a public offering price of $22.00 per share (the "Common Stock"). The offering consisted of ...

JBDI Holdings Limited Ordinary Shares’ (NASDAQ:JBDI – Get Free Report) lock-up period is set to end on Monday, February 24th. JBDI Holdings Limited Ordinary Shares had issued 2,250,000 shares in its ...

The purchase price of each pre-funded warrant will equal the price per share at which ordinary shares are being sold to the public in this offering, minus $0.001, which will be the exercise price ...

Hims & Hers has capitalized on the outsize consumer demand for obesity drugs. (Hims & Hers Health) Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug ...

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $60.30, moving +1.88% from the previous trading session. The stock's change was more than the S&P 500's daily loss of 0.01%.

Wolfe Research lowered shares of Robinhood Markets (NASDAQ:HOOD – Free Report) from an outperform rating to a peer perform ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...